Prelude Capital Management, LLC Cassava Sciences Inc Call Options Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022
SELL
$32.6 - $53.05 $159,740 - $259,945
-4,900 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$36.77 - $90.91 $180,173 - $445,459
4,900 New
4,900 $214,000
Q3 2020

Nov 16, 2020
SELL
$2.86 - $11.51 $5,148 - $20,718
-1,800 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$2.04 - $9.64 $3,672 - $17,352
1,800 New
1,800 $6,000

Others Institutions Holding SAVA

# of Institutions
201
Shares Held
13.9M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $110M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email